|
|
|
|
|
|
|
En route for tomorrow’s Solvay Pharmaceuticals
Solvay Pharmaceuticals operates in two main therapeutic areas, in which it undertakes a full range of Research and Development activities:
- Cardiometabolics (including the fenofibrate franchise);
- Neuroscience.
Supplementing these are several areas in which major medical needs exist, and where R&D support is selective and individualized:
- Flu vaccines;
- Pancreatic enzymes;
- Women’s and men’s health;
- Gastroenterology.
 Sales Breakdown 2007: EUR 2 591 million
By therapeutic field
 By geographic area
|
- Europe
36% European Union (27)
9% Other European countries)
- The Americas
40% Nafta
2% Mercosur
- Asia-Pacific
- Rest of the world
|
45 %
42 %
9 %
4 % |
|
|
|
|
|
|
